AlloVir, Inc. (ALVR)
USD 0.45
(-1.53%)
USD 0.45
(-1.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -124.45 Million | -142.05 Million | -106.31 Million | -60.81 Million | -20.15 Million | 1.94 Million |
| Net Income | -190.41 Million | -168.71 Million | -171.96 Million | -69.78 Million | -23.83 Million | -2.43 Million |
| Depreciation & Amortization | 398 Thousand | 723 Thousand | 189 Thousand | 73 Thousand | 19 Thousand | 3.03 Million |
| Deferred income taxes | 2.51 Million | - | 1.19 Million | - | - | - |
| Stock-based compensation | 40.77 Million | 41.31 Million | 43.97 Million | 9.42 Million | 2.89 Million | 967 Thousand |
| Change in working capital | 2.02 Million | -16.14 Million | 19.35 Million | -1.03 Million | 1.39 Million | 3.4 Million |
| Other non-cash items | 20.25 Million | 766 Thousand | 928 Thousand | 502 Thousand | -620 Thousand | -3.03 Million |
| Investing Cash Flow | 37.98 Million | -80.47 Million | 185.98 Million | -169.49 Million | -64.64 Million | - |
| Investments in PPE | - | 104 Thousand | -26 Thousand | -235 Thousand | -339 Thousand | - |
| Acquisitions | - | - | -186 Thousand | 169.26 Thousand | 64.3 Thousand | - |
| Investment purchases | -125.82 Million | -228.8 Million | -76.59 Million | -300.26 Million | -119.3 Million | - |
| Sales/Maturities of investments | 163.81 Million | 148.32 Million | 262.6 Million | 131 Million | 55 Million | - |
| Other Investing Activities | 37.98 Thousand | -104 Thousand | 186 Thousand | -169.26 Thousand | -64.3 Thousand | - |
| Financing Cash Flow | 70.49 Million | 126.96 Million | 232 Thousand | 291.97 Million | 120.92 Million | 22.87 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -10 Million |
| Common Stock Issuance | 70.49 Million | 126.42 Million | 232 Thousand | 295.44 Million | 120.92 Million | 32.87 Million |
| Other Financing Activities | 326 Thousand | 536 Thousand | 232.00 | -3.47 Million | -330 Thousand | 32.87 Million |
| Accounts receivables | -49 Thousand | -107 Thousand | 400 Thousand | 110 Thousand | -258 Thousand | 170 Thousand |
| Accounts payables | -2.51 Million | -12.62 Million | 20.29 Million | 2.72 Million | 4.93 Million | 601 Thousand |
| Inventory | - | 107 Thousand | -400 Thousand | -110 Thousand | 258 Thousand | - |
| Other working capital | 4.58 Million | -3.52 Million | -936 Thousand | -3.75 Million | -3.54 Million | 2.8 Million |
| Cash at beginning of period | 106.09 Million | 202.51 Million | 122.66 Million | 61.08 Million | 24.96 Million | 145 Thousand |
| Cash at end of period | 90.12 Million | 106.94 Million | 202.51 Million | 122.66 Million | 61.08 Million | 24.96 Million |
| Capital Expenditure | - | 104 Thousand | -26 Thousand | -235 Thousand | -339 Thousand | - |
| Effect of forex changes on cash | - | - | -44 Thousand | -90 Thousand | - | - |
| Net cash flow / Change in cash | -15.97 Million | -95.56 Million | 79.85 Million | 61.57 Million | 36.12 Million | 24.81 Million |
| Free Cash Flow | -124.45 Million | -141.94 Million | -106.34 Million | -61.04 Million | -20.49 Million | 1.94 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.07 Million | -30.29 Million | -190.41 Million | -59.69 Million | -44.27 Million | -45.26 Million |
| Depreciation & Amortization | - | - | 398 Thousand | 141 Thousand | 86 Thousand | 85 Thousand |
| Deferred income taxes | - | - | 2.51 Million | -15.8 Million | -1.23 Million | -524 Thousand |
| Stock-based compensation | 5.9 Million | 5.03 Million | 40.77 Million | 9.99 Million | 10.46 Million | 10.28 Million |
| Change in working capital | -9.05 Million | -12.86 Million | 2.02 Million | -2.63 Million | -3.08 Million | 8.52 Million |
| Other non-cash items | 13.4 Million | 14.49 Million | 20.25 Million | 37.26 Million | 3.55 Million | -228 Thousand |
| Investing Cash Flow | 30 Million | 40 Million | 37.98 Million | 25.21 Million | -66.85 Million | 37.89 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -125.82 Million | -9.78 Million | -101.85 Million | -2.44 Million |
| Sales/Maturities of investments | 30 Million | 40 Million | 163.81 Million | 34.99 Million | 34.99 Million | 40.33 Million |
| Other Investing Activities | - | 40 Million | 37.98 Thousand | 25.21 Thousand | -66.85 Thousand | 37.89 Thousand |
| Financing Cash Flow | 21 Thousand | - | 70.49 Million | 11 Thousand | - | 70.48 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 21 Thousand | - | 70.49 Million | 11 Thousand | - | 70.48 Million |
| Other Financing Activities | - | - | 326 Thousand | 11.00 | - | 70.48 Thousand |
| Accounts receivables | 84 Thousand | 26 Thousand | -49 Thousand | 28 Thousand | -128 Thousand | 138 Thousand |
| Accounts payables | -9.67 Million | -15.73 Million | -2.51 Million | -5.55 Million | -1.86 Million | 5.39 Million |
| Inventory | - | - | - | 705 Thousand | 128 Thousand | -138 Thousand |
| Other working capital | 541 Thousand | 2.83 Million | 4.58 Million | 2.89 Million | -1.21 Million | 3.13 Million |
| Cash at beginning of period | 86.03 Million | 90.12 Million | 106.09 Million | 95.62 Million | 197.8 Million | 116.55 Million |
| Cash at end of period | 104.74 Million | 86.03 Million | 90.12 Million | 90.12 Million | 96.47 Million | 197.8 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 18.7 Million | -4.08 Million | -15.97 Million | -5.5 Million | -101.32 Million | 81.25 Million |
| Free Cash Flow | -11.31 Million | -44.38 Million | -124.45 Million | -30.73 Million | -34.47 Million | -27.12 Million |
3889
2243
8142
RIBS
047040
1TY